Obesity — Trials, FDA Actions & Pivotal Research
102 updates aggregated from openFDA and ClinicalTrials.gov, covering trial milestones, FDA actions, and pivotal publications about Obesity.
Synced daily from openFDA and ClinicalTrials.gov. Last sync: .
Drugs with Obesity trials
Recruiting trials by city
Cities where Obesity trials in our archive had recruiting sites. Each link lists every currently recruiting paid clinical trial at that location.
Updates
2026
- Results postedGlycemic Screening Outreach Pilot Trial Results Posted for Obesity· May 15, 2026
- Results postedFirst Heroes Intervention Shows Lower Infant Weight Gain, Maternal Retention· May 11, 2026
- Results postedSemaglutide + Lower Insulin Glargine Reduces HbA1c, Weight in T2D· May 11, 2026· drug: Semaglutide
- Results postedSemaglutide Oral Tablet Shows Significant Weight Loss in Obesity Trial· May 7, 2026· drug: Semaglutide
- Results postedObesity: Tailored Weight Program Shows No Significant Benefit for Veterans…· May 6, 2026
- Primary completionSurvodutide SYNCHRONIZE™-CVOT Phase 3 Trial Reaches Primary Completion· May 1, 2026· drug: Survodutide
- Primary completionRetatrutide Phase 3 Trial for Obesity and Overweight Completes Primary Study· Apr 30, 2026· drug: Retatrutide
- Primary completionRetatrutide Phase 3 Trial for Obesity and CVD Reaches Primary Completion· Apr 30, 2026· drug: Retatrutide
- Results postedSemaglutide 7.2 mg Shows Superior Weight Loss in Obesity, Type 2 Diabetes· Apr 27, 2026· drug: Semaglutide
- Results postedSemaglutide for Obesity: Phase 3 Trial Shows Significant Weight Loss vs. Placebo· Apr 23, 2026· drug: Semaglutide
- Primary completionCagriSema Phase 3 Study for Excess Body Weight Reaches Primary Completion· Apr 22, 2026· drug: CagriSema (Cagrilintide B and Semaglutide I)
- Results postedVirtual Cardiometabolic Program Reduces BP, Weight in African Immigrants· Apr 22, 2026
- Results postedMazdutide Phase 2 Trial for Obesity Shows Up to -22.3% Weight Reduction· Apr 21, 2026· drug: Mazdutide
- Results postedObesity: High Intensity Weight Loss Reduces Body Weight by 10.73 kg· Apr 3, 2026
- Results postedDepression: Mindfulness Intervention Trial Posts Feasibility Results· Apr 2, 2026
- Results postedObesity: Time Restricted Eating Trial Shows Changes in Metabolic and Cognitive…· Mar 27, 2026
- Primary completionOrforglipron Phase 3 Trial for Type 2 Diabetes and Obesity Completes Primary…· Mar 16, 2026· drug: Orforglipron
- Results postedObesity: Mindfulness-Based Behavioral Treatments Show Weight Loss· Mar 11, 2026
- Results postedSemaglutide Oral 25 mg Shows Significant Weight Loss in Overweight/Obesity· Feb 25, 2026· drug: Semaglutide
- Results postedSemaglutide Reduces Abdominal and Total Body Fat in HIV Lipohypertrophy· Feb 17, 2026· drug: Semaglutide
- Results postedMorbid Obesity & Epidural Analgesia: Ultrasound Device Matches Palpation· Feb 17, 2026
- Results postedObesity Trial: Structured Exercise Lowers Appetite in Adolescents· Feb 12, 2026
- Results postedSemaglutide Reduces Weight, Cravings, and Food Intake in Obesity Trial· Feb 10, 2026· drug: Semaglutide
- Results postedHARMONY Study Posts Mixed Results for Cardiometabolic Risk Factors· Jan 29, 2026
- Results postedObesity: Digital Intervention Messages Improve Daily Weighing Goal Achievement· Jan 27, 2026
- Results postedObesity: Antenatal Treatment Reduces Gestational Weight Gain· Jan 21, 2026
- Results postedObesity: Behavioral Weight Loss Intervention Shows Positive Pilot Results· Jan 21, 2026
- Primary completionTirzepatide Phase 3 Study for Weight Reduction Maintenance Completes Primary· Jan 20, 2026· drug: Tirzepatide
- Results postedObesity: Weight Stigma Manipulation Linked to Reduced Food Intake· Jan 20, 2026
- Results postedObesity: Gamified Digital Intervention Shows Greater Weight Loss Trend· Jan 15, 2026
- Results postedSemaglutide Achieves Greater Weight Loss vs. Other Obesity Medications· Jan 14, 2026· drug: Liraglutide
- Results postedObesity: BUD App Improves Healthy Food Sales, Acquisition Savings· Jan 14, 2026
- Results postedObesity: Neural Activation Patterns During Food Anticipation Results Posted· Jan 12, 2026
- Results postedObesity: Family Check-Up Heart Reduces Postpartum Weight Gain· Jan 12, 2026
- Results postedObesity Trial Results Posted for Behavioral Economics Intervention· Jan 9, 2026
- Results postedSemaglutide Plus NNC0165-1875 Reduces Body Weight in Obesity Study· Jan 8, 2026· drug: Semaglutide
- Primary completionIxekizumab Phase 3 Trial for Psoriasis and Obesity Completes Primary Phase· Jan 8, 2026· drug: Ixekizumab
2025
- Primary completionLiraglutide + Metformin Combination Trial for PCOS, Obesity, Infertility…· Dec 31, 2025· drug: Liraglutide
- Results postedObesity: Before-School Physical Activity Program Shows Minimal BMI Change· Dec 23, 2025
- Results postedObesity: WW Clinic GLP-1 Program Shows Mean Weight Loss of 27.41 Pounds· Dec 19, 2025
- Results postedDigital vs. Human Coaching for Diabetes Prevention: Key Results Posted· Dec 17, 2025
- Results postedObesity: FoodRx Trial Shows Modest Weight Loss with Food Supplementation· Dec 17, 2025
- Primary completionSurvodutide Phase 3 Trial for Obesity and Type 2 Diabetes Completes Primary…· Dec 12, 2025· drug: Survodutide
- Results postedObesity: Sleep Extension Trial Shows Mixed Metabolic Effects· Dec 11, 2025
- Primary completionCagriSema Trial for Obesity Reaches Primary Completion on December 8, 2025· Dec 8, 2025· drug: CagriSema (Cagrilintide B and Semaglutide I)
- Primary completionSurvodutide Phase 3 Trial for Japanese Obesity Completes Primary Data Collection· Dec 3, 2025· drug: Survodutide
- Primary completionSurvodutide Phase 3 Trial for Obesity Completes Primary Data Collection· Dec 2, 2025· drug: Survodutide
- Results postedSemaglutide in Obesity Trial: Tirzepatide Shows Superior Weight Reduction· Nov 26, 2025· drug: Semaglutide
- Results postedObesity: Exercise Improves Muscle Strength, Lean Mass, and Fat Percentage· Nov 25, 2025
- Results postedObesity: Mindfulness Intervention Shows Weight Gain in Regain Prevention Study· Nov 25, 2025
- Results postedObesity: Pilot Study Results Posted for Lifestyle Modification Trial· Nov 24, 2025
- Primary completionOrforglipron Phase 3 Trial for Obesity, Overweight Completes Primary Endpoint· Nov 21, 2025· drug: Orforglipron
- Results postedObesity: Trial Results Posted for Daytime vs. Delayed Eating Study· Nov 21, 2025
- Results postedObesity: Virtual Coach and Standard Tools Show Similar Weight Loss· Nov 20, 2025
- Results postedObesity: Clinical Referral to Activity Study Posts 12-Month Results· Nov 19, 2025
- Primary completionIxekizumab + Tirzepatide Phase 3 Trial for Psoriatic Arthritis & Obesity…· Nov 18, 2025· drug: Ixekizumab
- Results postedStretching Intervention Curbs Blood Pressure Rise in Pregnant Women with Obesity· Nov 17, 2025
- Primary completionRetatrutide Phase 3 Trial for Obesity and Knee OA Completes Primary Study Period· Nov 14, 2025· drug: Retatrutide
- Results postedObesity: HEALTH Intervention Shows Modest Weight Loss in Phase 3 Trial· Nov 12, 2025
- Results postedObesity: Online Family Skills Training Shows Greater Weight Loss· Nov 6, 2025
- Results postedObesity: Whole-Muscle Protein Synthesis Lower in Participants· Nov 5, 2025
- Results postedObesity and Polyneuropathy: Exercise and Surgery Trial Results Posted· Oct 29, 2025
- Results postedObesity: Combined ESG + HAPC Shows Improved Durability in Trial· Oct 23, 2025
- Results postedObesity Trial: Lifestyle Intervention Demonstrates Positive Outcome Differences· Oct 21, 2025
- Results postedObesity: Adaptive vs. Static Extended Care Trial Results Posted· Oct 20, 2025
- Results postedObesity: Lifestyle Program for OSA Shows High System Usability· Oct 16, 2025
- Results postedDapagliflozin Combination Shows Lower Mean Weight in Obesity, Pre-Diabetes, T2D· Oct 15, 2025· drug: Dapagliflozin
- Primary completionSemaglutide Phase 3 Trial for Pediatric Obesity Completes Primary Data…· Oct 15, 2025· drug: Semaglutide
- Results postedObesity: Time-Restricted Eating Shows Greater Weight and Body Fat Reduction· Oct 14, 2025
- Results postedObesity: Bariatric Surgery Reduces Liver Fat in Adolescents· Oct 10, 2025
- Primary completionSurvodutide Phase 3 Trial for Obesity and NASH Completes Primary Data Collection· Oct 9, 2025· drug: Survodutide
- Results postedObesity: ADF Plus Exercise Significantly Reduces Liver Fat, Body Weight· Sep 25, 2025
- Primary completionMazdutide Phase 3 Trial for Type 2 Diabetes and Obesity Reaches Primary…· Sep 17, 2025· drug: Mazdutide
- Results postedObesity: Multi-country Study Shows Varied Weight Changes Across Populations· Sep 17, 2025
- Results postedObesity: Pre-NDPP Shows Slightly Higher Weight Loss Than Usual Care· Sep 5, 2025
- Results postedTirzepatide Phase 1 Pediatric Obesity Trial Shows High TEAE Incidence· Aug 26, 2025· drug: Tirzepatide
- Results postedTirzepatide SUMMIT Trial for HFpEF and Obesity Improves KCCQ Scores, Reduces…· Aug 20, 2025· drug: Tirzepatide
- Results postedObesity Implementation Trial: Staff Metrics Show Overall Improvement· Aug 20, 2025
- Results postedObesity: EndoZip System Shows 13.2 kg Mean Weight Loss at 12 Months· Aug 13, 2025
- Results postedSemaglutide Adjunct Therapy Hits Composite Endpoint in Type 1 Diabetes· Aug 12, 2025· drug: Semaglutide
- Results postedObesity: Noom Health Shows Lower Mean Weights Than Digital Health· Aug 11, 2025
- Primary completionOrforglipron Phase 3 Trial for Obesity and Type 2 Diabetes Completes Primary…· Aug 8, 2025· drug: Orforglipron
- Results postedObesity: Meal Delivery Feasibility Assessed in Postpartum Women· Aug 5, 2025
- Results postedObesity: Behavioral Weight Loss Intervention Reduces Weight· Jul 30, 2025
- Primary completionSurvodutide Phase 3 Trial for Overweight/Obesity in Chinese Slated for Primary…· Jul 29, 2025· drug: Survodutide
- Primary completionOrforglipron Phase 3 Trial for Obesity/Overweight Completes Primary Phase· Jul 25, 2025· drug: Orforglipron
- Results postedObesity: Mobile Integrated Care Reduces Child Adiposity in Pilot Study· Jul 24, 2025
- Results postedObesity: MATADORS Feasibility Study Results Posted for App Intervention· Jul 23, 2025
- Results postedObesity Trial Explores Digital Intervention Components, Reports Weight Loss· Jul 20, 2025
- Results postedSemaglutide with Bimagrumab Shows Enhanced Weight Loss in Obesity· Jul 18, 2025· drug: Semaglutide
- Results postedObesity: Family Diabetes Prevention Program Pilot Study Attendance Results…· Jul 8, 2025
- Primary completionMazdutide Phase 3 Trial for Obesity Reaches Primary Completion· Jun 27, 2025· drug: Mazdutide
- Primary completionOrforglipron Trial for Obesity in Japanese Adults Reaches Primary Completion· Jun 19, 2025· drug: Orforglipron
- Results postedObesity: CONTRAVE® Shows Lower MACE Incidence in Real-World Study· Jun 17, 2025
- Results postedObesity: Green Tea Confection Linked to Lower Endotoxin Levels· Jun 13, 2025
- Results postedObesity: Exercise Alters Gut Microbiome and Cardiometabolic Markers· Jun 13, 2025
- Results postedObesity: Intervention Reduces Child BMI Z-score in Early Care Settings· Jun 12, 2025
- Results postedObesity: EHR-Embedded Interventions Show Modest BMI Reduction· Jun 12, 2025
- Results postedObesity: Move Program Shows Strong Acceptability and Feasibility· Jun 10, 2025
- Results postedObesity Trial PREMIER: Genotype Group Shows Lower Glucose Levels· Jun 8, 2025
- Results postedPediatric Obesity: Feasibility Trial for Meal Kit Intervention Posts Results· May 22, 2025
- Results postedObesity: Calibrated Formula Feeding Results Posted for Infant Growth· May 21, 2025